Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-cypher registry

Circulation

Volumn 122, Issue 1, 2010, Pages 42-51

  Abe, Mitsuru ^a   Kimura, Takeshi ^b   Morimoto, Takeshi ^b   Taniguchi, Takuya ^a   Yamanaka, Futoshi ^a   Nakao, Kazuhiro ^a   Yagi, Nobuhito ^a   Kokubu, Nobuaki ^a   Kasahara, Yoichiro ^a   Kataoka, Yu ^a   Otsuka, Yoritaka ^a   Kawamura, Atsushi ^c   Miyazaki, Shunichi ^d   Nakao, Koichi ^h   Horiuchi, Kenji ^h   Ito, Akira ^e   Hoshizaki, Hiroshi ⁱ   Kawaguchi, Ren ⁱ   Setoguchi, Manabu ^j   Inada, Tsukasa ^f   Kishi, Koichi ^k   Sakamoto, Hiroki ^l   Morioka, Nobuyuki ^g   Imai, Masao ^m   Shiomi, Hiroki ^b   Nonogi, Hiroshi ^a   Mitsudo, Kazuaki ^m   more..

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Central Hospital   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f OSAKA RED CROSS HOSPITAL   (Japan)

^g Kishiwada Tokushukai Hospital   (Japan)

^h SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

ⁱ Gunma Pref Cardiovascular Center   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^k TOKUSHIMA RED CROSS HOSPITAL   (Japan)

^l JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^m KURASHIKI CENTRAL HOSPITAL   (Japan)

more..

Author keywords

angioplasty; balloon; restenosis; stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; INSULIN; RAPAMYCIN; TICLOPIDINE;

AGED; ANGIOGRAPHY; ARTICLE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; SIROLIMUS;

EID: 77954624627     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.905802     Document Type: Article

References (18)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315-1323.
2. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297:2001-2009.
3. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119:987-995.
4. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005, 293, 165-171
5. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez-Minguez JR, Angel J, Mantilla R, Moris C, Cequier A, Sabate M, Escaned J, Moreno R, Banuelos C, Suarez A, Macaya C. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol. 2006;47:2152-2160. (Pubitemid 43795079)
6. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Fernandez C, Escaned J, Banuelos C, Bethencourt A, Lopez-Minguez JR, Angel J, Cequier A, Sabate M, Moris C, Zueco J, Seabra-Gomes R. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv. 2008;72:459-467.
7. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295: 1264-1273.
8. Cosgrave J, Melzi G, Biondi-Zoccai GG, Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M, Bonizzoni E, Colombo A. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol. 2006;47:2399-2404.
9. Kitahara H, Kobayashi Y, Takebayashi H, Fujimoto Y, Nakamura Y, Kuroda N, Himi T, Miyazaki A, Haruta S, Komuro I. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals. Circ J. 2009; 73:867-871.
10. Kim YH, Lee BK, Park DW, Park KH, Choi BR, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol. 2006;98:1451-1454.
11. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351.
12. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193-1202.
13. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-1878.
14. Corbett SJ, Cosgrave J, Melzi G, Babic R, Biondi-Zoccai GG, Godino C, Morici N, Airoldi F, Michev I, Montorfano M, Sangiorgi GM, Bonizzoni E, Colombo A. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus-and paclitaxel-eluting stents. Eur Heart J. 2006;27:2330-2337.
15. Park CB, Hong MK, Kim YH, Park DW, Han KH, Lee CW, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Comparison of angiographic patterns of in-stent restenosis between sirolimus-and paclitaxel-eluting stent. Int J Cardiol. 2007;120:387-390.
16. Byrne RA. ISAR-DESIRE 2: A prospective randomized trial of paclitaxel-eluting vs sirolimus-eluting stents for treatment of sirolimus-eluting stent restenosis. Oral presentation, Transcatheter Cardiovascular Therapeutics 2009; September 23, 2009; San Francisco, CA.
17. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-2124.
18. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-2994.